Blog / Archives
Biotech Stocks are Lagging, Position your portfolio for a Q4 Rally with the XBI. Update-2 Downdraft!
Update-2 Downdraft surprises investors-momentum shift ! We have been talking about this for weeks, How much higher can the FAANG names go? The momentum is unprecedented. Bifurcated market. Well...
Tough Time To Trade Biotech Stocks, Is the Momentum Market Easing?…Update-4 ABT Rapid Test!
We took profits on many longs and shorts in the coronavirus sector so I will need to look at new trades for Q4. Our small longs for now are ABT, AZT, GNMK, GILD, MRNA, MRK, OSUR and TDOC. However...
Biotech Momentum Stalled: Headwinds Remain for August.Update-3 Flattish week with healthcare lagging
August 15..Update -3...Momentum slows to a walk but XBI holds the $110 handle. XLV flat at $107 level, IBB down 0.86% to $133.30. Coronavirus stocks still within 10% of 52 week highs: HOLX,REGN;...
Speculative Rally in Biotech Today, Is the Correction Over Already? Update-1
Update-1 Aug 6 Coronavirus Stocks Get Hit in Profit Taking Mode-Vaccine Stocks are Weak Momentum continues to ebb : XBI down 0.51% to $113.81, red screen day. Virus high fliers take a hit: BNTX down...
Biotech Traders Will Face Strong Headwinds…Update-4 BIG Tech Rules!
Update-4 Early am trading shows weakness in COVID vaccine stocks ; Investors are focused on BIG TECH.XBI down 2% to $109 level. Vaccines require constant feeding with news flow: AZN BNTX INO MRNA...
Biotech Portfolio Review: What to do Next? Update-4 Vaccine Stocks Weak
Update-4 JY 23 Midday trading: Reiterate-take Profits on COVID Vaccine stocks Big Sell-Off Today: BNTX, INO, MRNA, NVAX. Antiviral stocks REGN VIR holding up. Review and update after the close. XBI...
Coronavirus Stocks: Take a Breather-The Easy Trades Have Been Done …Update-4 AZN MRNA
Update-4 7/15 1:30P...Volatlity hits COVID vaccine players; BNTX, INO, NVAX down, MRNA up. Comment from CNBC contributor: "maybe vaccine news is priced in", shows how hard it is to play daily news...
Volatile Week for Coronavirus Stocks: COVID Vaccines are in Focus…Update-5
Update-5 JY 7 After close with NASDAQ down 0.86%, but biotechs hold. Genmark (GNMK) up 10.33% AH to $17.22 on Preliminary q2 Results. Revs of $40.1M, a 118% increase over Q2 2019, Placed 71 new...
Biotech Breakout -XBI: Portfolio Notes and Composition Update-3
Update-3...June 25-Re-opening Paused in FLA and TX-but stocks rally anyway. NASDAQ leads up 11% YTD. Trading remains volatile e.g. VIR. Bullish trend intact for biotech IBB up 1.11%. Vaccine stocks...
What’s Next for Coronavirus Stocks? Diagnostics are the Near Term Focus…Update-2
Update-2 6/20...Strong finish for biotech on Friday with XBI up 2.83% to $108.85, up 5.64% for week; and one year high. Coronavirus strong stocks for the week: GNMK HOLX NVAX RGEN TDOC VIR . Quidel...